Literature DB >> 7931308

Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro.

J P Usenius1, P Vainio, J Hernesniemi, R A Kauppinen.   

Abstract

We have studied 14 patients with different grades of astrocytomas using 1H NMR spectroscopy in vivo. Typically, astrocytomas exhibited a low N-acetylaspartate peak, a prominent signal from choline group-containing compounds, and lactate in the 1H NMR spectra in vivo. The uncorrected choline/creatine + phosphocreatine peak area ratios were higher in tumors than in normal brain tissue. Absolute concentration of choline-containing compounds (1.74 +/- 0.09 mmol/L) in the normal brain tissue was not different in any grade of astrocytoma, but total creatine concentration in healthy brain (7.49 +/- 0.30 mmol/L) was higher than that in grade IV astrocytomas (4.84 +/- 0.89 mmol/L). Relaxation constants of choline-containing compounds did not differ in tumors from those determined in normal brain. Perchloric acid extracts of biopsy samples from 35 astrocytomas and 13 samples of normal temporal white matter were analyzed with 1H NMR. Total concentration of choline-containing compounds did not differ between controls and any grade of astrocytoma when the quantification was done in vitro. It is interesting that phosphorylcholine concentration was about twofold greater in grade IV astrocytomas than in controls or other grades of astrocytomas. We conclude that high phosphorylcholine in grade IV astrocytomas may be an indicator of degree of malignancy. The proportional changes within the group of choline-containing compounds observed in vitro were not reflected in the NMR properties of choline signal in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931308     DOI: 10.1046/j.1471-4159.1994.63041538.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  29 in total

Review 1.  Metabolomic signature of brain cancer.

Authors:  Renu Pandey; Laura Caflisch; Alessia Lodi; Andrew J Brenner; Stefano Tiziani
Journal:  Mol Carcinog       Date:  2017-07-17       Impact factor: 4.784

2.  Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo.

Authors:  Xiaojuan Li; Daniel B Vigneron; Soonmee Cha; Edward E Graves; Forrest Crawford; Susan M Chang; Sarah J Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

3.  Quantification of metabolites from single-voxel in vivo 1H NMR data of normal human brain by means of time-domain data analysis.

Authors:  M Ala-Korpela; J P Usenius; J Keisala; A van den Boogaart; P Vainio; J Jokisaari; S Soimakallio; R Kauppinen
Journal:  MAGMA       Date:  1995 Sep-Dec       Impact factor: 2.310

4.  Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy.

Authors:  Suja Saraswathy; Forrest W Crawford; Kathleen R Lamborn; Andrea Pirzkall; Susan Chang; Soonmee Cha; Sarah J Nelson
Journal:  J Neurooncol       Date:  2008-09-23       Impact factor: 4.130

5.  Comparison of T(1) and T(2) metabolite relaxation times in glioma and normal brain at 3T.

Authors:  Yan Li; Radhika Srinivasan; Helene Ratiney; Ying Lu; Susan M Chang; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2008-08       Impact factor: 4.813

6.  Proton and phosphorous MR spectroscopy in squamous cell carcinomas of the head and neck.

Authors:  Sanjeev Chawla; Sungheon Kim; Laurie A Loevner; Harry Quon; Sumei Wang; Faith Mutale; Gregory Weinstein; Edward J Delikatny; Harish Poptani
Journal:  Acad Radiol       Date:  2009-07-15       Impact factor: 3.173

7.  Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers.

Authors:  Alan J Wright; Greg A Fellows; John R Griffiths; M Wilson; B Anthony Bell; Franklyn A Howe
Journal:  Mol Cancer       Date:  2010-03-23       Impact factor: 27.401

8.  Taurine: a potential marker of apoptosis in gliomas.

Authors:  K S Opstad; B A Bell; J R Griffiths; F A Howe
Journal:  Br J Cancer       Date:  2009-02-17       Impact factor: 7.640

9.  Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1H MRS).

Authors:  M Lindskog; P Kogner; F Ponthan; P Schweinhardt; B Sandstedt; T Heiden; G Helms; C Spenger
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

10.  ¹H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice.

Authors:  S K Hekmatyar; M Wilson; N Jerome; R M Salek; J L Griffin; A Peet; R A Kauppinen
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.